A Case-Control Comparison of the Effectiveness of Betamethasone to Prevent Neonatal Morbidity and Mortality in Preterm Twin and Singleton Pregnancies

ABSTRACT

We compared the effectiveness of antenatal betamethasone for the prevention of neonatal morbidity and mortality in preterm twin and singleton gestations. We conducted a case-control study of women with twin versus singleton gestations who received betamethasone for risk of prematurity in a university-affiliated, community-based, tertiary care center between 1997 and 2005. Cases were identified from clinical care and pharmacy databases, then matched for neonatal gender and gestational age (GA) at delivery. Sixty cases and 60 controls of deliveries occurring between 24 and 34 weeks' gestation were identified. The mean GA was 30.4 ± 2.7 weeks. There were no differences between the groups in maternal demographics (with the exception of maternal age), birth weight, head circumference, Apgar scores, need for mechanical ventilation, days on ventilator, intraventricular hemorrhage grade 3 or 4, necrotizing enterocolitis suspected sepsis, total days in neonatal intensive care unit, or neonatal deaths. No differences in major morbidities or mortality were found in singletons versus twins. Concerns that the added maternal plasma volume in multiple gestations could lessen the neonatal benefits of antenatal betamethasone were not substantiated. This study may be affected by β-error due to small sample size and sampling bias as a result of a retrospective study.

KEYWORDS

Betamethasone - twin gestation - prematurity

REFERENCES

• 1 NIH Consensus Development Panel . Effect of corticosteroids for fetal maturation on perinatal outcomes.  JAMA. 1995;  273 413-418
• 2 Dudley D J, Waters T P, Nathanielsz P W. Current status of single-course antenatal steroid therapy.  Clin Obstet Gynecol. 2003;  46 132-149
• 3 Guinn D A, Atkinson M W, Sullivan L et al.. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial.  JAMA. 2001;  286 1581-1587
• 4 Warner B B, Kiely J L, Donovan E F. Multiple births and outcome.  Clin Perinatol. 2000;  27 347-361
• 5 Martin J A, Hamilton B E, Sutton P D et al.. Births: final data for 2004.  Natl Vital Stat Rep. 2006;  55 1-101
• 6 Joseph K S, Allen A C, Dodds L et al.. Causes and consequences of recent increases in preterm birth among twins.  Obstet Gynecol. 2001;  98 57-64
• 7 Martin J A, Hamilton B E, Sutton P D, Ventura S J, Menacker F, Munson M L. Births: final data for 2002.  Natl Vital Stat Rep. 2003;  52 1-113
• 8 Jobe A H, Soll R F. Choice and dose of corticosteroid for antenatal treatments.  Am J Obstet Gynecol. 2004;  190 878-81
• 9 Crowley P. Corticosteroids prior to preterm delivery (Cochrane Review). The Cochrane Library. Issue 4, update software. Oxford; 1998
• 10 Ballard P L, Ballard R A. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids.  Am J Obstet Gynecol. 1995;  173 254-262
• 11 Jeffray T M, Marinoni E, Ramirez M M, Bocking A D, Challis J R. Effect of prenatal betamethasone administration on maternal and fetal corticosteroid-binding globulin concentrations.  Am J Obstet Gynecol. 1999;  181 1546-1551
• 12 Challis J R, Berdusco E T, Jeffray T M, Yang K, Hammond G L. Corticosteroid-binding globulin (CBG) in fetal development.  J Steroid Biochem Mol Biol. 1995;  53 523-527
• 13 Ballabh P, Lo E S, Kumari J et al.. Pharmacokinetics of betamethasone in twin and singleton pregnancy.  Clin Pharmacol Ther. 2002;  71 39-45
• 14 Pacheco L D, Ghulmiyyah L M, Snodgrass W R, Hankins G D. Pharmacokinetics of corticosteroids during pregnancy.  Am J Perinatol. 2007;  24 79-82
• 15 Rotmensch S, Lev S, Kovo M et al.. Effect of betamethasone administration on fetal heart rate tracing: a blinded longitudinal study.  Fetal Diagn Ther. 2005;  20 371-376
• 16 Mulder E J, Derks J B, Visser G H. Effects of antenatal betamethasone administration on fetal heart rate and behavior in twin pregnancy.  Pediatr Res. 2004;  56 35-39
• 17 Ville Y, Vincent Y, Tordjman N, Hue M V, Fernandez H, Frydman R. Effect of betamethasone on the fetal heart rate pattern assessed by computerized cardiotocography in normal twin pregnancies.  Fetal Diagn Ther. 1995;  10 301-306
• 18 Mulder E J, Derks J B, Visser G H. Effects of antenatal betamethasone administration on fetal heart rate and behavior in twin pregnancy.  Pediatr Res. 2004;  56 35-39
• 19 Ardila J, Le Guennec J C, Papageorgiou A. Influence of antenatal betamethasone and gender cohabitation on outcome of twin pregnancies 24 to 34 weeks of gestation.  Semin Perinatol. 1994;  18 15-18
• 20 Spinillo A, Capuzzo E, Ometto A et al.. Value of antenatal corticosteroids therapy in preterm birth.  Early Hum Dev. 1995;  42 37-47
• 21 Turrentine M A, Dupras-Wilson P, Wilkins I A. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies.  Am J Perinatol. 1996;  13 351-354
• 22 Quist-Therson E C, Myhr T L, Ohlsson A. Antenatal steroids to prevent respiratory distress syndrome: multiple gestation as an effect modifier.  Acta Obstet Gynecol Scand. 1999;  78 388-392
• 23 Marttila R, Kaprio J, Hallman M. Respiratory distress syndrome in twin infants compared with singletons.  Am J Obstet Gynecol. 2004;  191 271-276
• 24 Blickstein I, Shinwell E S, Lusky A, Reichman B. Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment.  Am J Obstet Gynecol. 2005;  192 360-364